Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

This study has been completed.
Sponsor:
Information provided by:
University of Utah
ClinicalTrials.gov Identifier:
NCT00810784
First received: December 16, 2008
Last updated: December 17, 2008
Last verified: December 2008

December 16, 2008
December 17, 2008
March 2005
March 2007   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00810784 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients

VTE prophylaxis is not as routinely employed in medically ill patients as compared to surgical patients. This retrospective chart review project will evaluate the effectiveness of VTE prophylaxis in medically ill patients at the University of Utah Hospitals and Clinics compared to current literature. The study will ultimately serve as a quality improvement project to help improve patient care.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Data was collected on consecutive patients ≥18 years with a hospital length of stay of >48 hours admitted to the cardiology, pulmonary, or general medical services. Admission dates were a sample of two different two-week blocks (January 1-14, 2006 and April 1-14, 2006). These blocks were chosen to be consistent with dates of analysis in the pre-intervention cohort. Patients receiving therapeutic anticoagulation were excluded.

Venous Thromboembolism
Behavioral: Education
(1) a risk-assessment tool completed at the time of a hospital admission, (2) structured educational sessions on VTE prevention, and (3) audit-feedback where institutional data was reviewed during the educational sessions. These sessions were given once to the clinical pharmacists and on three separate occasions to the medicine house officers.
  • 1
    Patients cared for before our intervention.
  • 2
    Patients cared for after our intervention.
    Intervention: Behavioral: Education
Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol. 2005 Mar;78(3):167-72.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
121
March 2007
March 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hospitalized at the University of Utah on one our medical services.

Exclusion Criteria:

  • Patients received therapeutic anticoagulation.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00810784
UUHSC-IRB-00018164
Yes
Robert Pendleton, M.D., Associate Professor, University of Utah, University of Utah
University of Utah
Not Provided
Principal Investigator: Matthew Rondina, M.D. University of Utah
University of Utah
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP